LATEST NEWS

Exact Therapeutics receives regulatory approval to reopen the ACTIVATE clinical trial

Exact Therapeutics awarded NOK 16 million from the Norwegian Research Council for collaboration project with NTNU, ICR and TGen

EXACT Therapeutics and TGen publish preclinical data on Acoustic Cluster Therapy combined with chemotherapy in a pancreatic cancer model

Mandatory notification of trade in connection with grant of options to CEO
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer